Intervention: Zanubrutinib, Polatuzumab vedotin and Rituximab
Found 11 matching trials
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2
This is a prospective, multicenter, single-arm, open phase II study to expl...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes
PHASE2
This is a prospective, open-label, single-arm, single-center, Phase II clin...